Yazji Salim's most recent trade in Oncternal Therapeutics Inc was a trade of 14,200 Stock Option done . Disclosure was reported to the exchange on Feb. 14, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics Inc | Yazji Salim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 14,200 | 14,200 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Salim Yazji | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. | 03 Jan 2024 | 19,742 | 128,635 (0%) | 0% | 0.5 | 9,794 | Common Stock |
| Oncternal Therapeutics Inc | Salim Yazji | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.36 per share. | 03 Jul 2023 | 16,299 | 148,377 (0%) | 0% | 0.4 | 5,868 | Common Stock |
| Oncternal Therapeutics Inc | Salim Yazji | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.28 per share. | 12 Apr 2023 | 10,000 | 149,676 (0%) | 0% | 0.3 | 2,850 | Common Stock |
| Oncternal Therapeutics Inc | Salim Yazji | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.28 per share. | 12 Apr 2023 | 10,000 | 159,676 (1%) | 0% | 0.3 | 2,850 | Common Stock |
| Oncternal Therapeutics Inc | Salim Yazji | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.30 per share. | 12 Apr 2023 | 5,000 | 164,676 (1%) | 0% | 0.3 | 1,500 | Common Stock |
| Oncternal Therapeutics Inc | Salim Yazji | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 210,000 | 210,000 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Salim Yazji | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.02 per share. | 03 Jan 2023 | 9,961 | 139,676 (0%) | 0% | 1.0 | 10,160 | Common Stock |
| Oncternal Therapeutics Inc | Salim Yazji | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 82,500 | 149,637 (0%) | 0% | 0 | Common Stock | |
| Oncternal Therapeutics Inc | Salim Yazji | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 55,000 | 55,000 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Salim Yazji | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 27 Jan 2022 | 10,000 | 67,137 (0%) | 0% | 1.7 | 16,900 | Common Stock |
| Oncternal Therapeutics Inc | Salim Yazji | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 92,075 | 92,075 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Salim Yazji | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 57,137 | 57,137 (0%) | 0% | 0 | Common Stock |